About biotricity inc - BTCY
Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. Its products include Bioflux, Biocore, Bioheart, Biokit, and Biocare. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on January 25, 2011 and is headquartered in Redwood City, CA.
BTCY At a Glance
Biotricity, Inc.
203 Redwood Shores Parkway
Redwood City, California 94065
| Phone | 1-800-590-4155 | Revenue | 13.79M | |
| Industry | Packaged Software | Net Income | -8,421,179.00 | |
| Sector | Technology Services | 2025 Sales Growth | 14.316% | |
| Fiscal Year-end | 03 / 2026 | Employees | 46 | |
| View SEC Filings |
BTCY Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.531 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -17.233 |
| Enterprise Value to Sales | 2.541 |
| Total Debt to Enterprise Value | 0.745 |
BTCY Efficiency
| Revenue/Employee | 299,789.00 |
| Income Per Employee | -183,069.109 |
| Receivables Turnover | 8.314 |
| Total Asset Turnover | 2.381 |
BTCY Liquidity
| Current Ratio | 0.225 |
| Quick Ratio | 0.149 |
| Cash Ratio | 0.018 |
BTCY Profitability
| Gross Margin | 76.608 |
| Operating Margin | -17.759 |
| Pretax Margin | -61.066 |
| Net Margin | -61.066 |
| Return on Assets | -145.399 |
| Return on Equity | N/A |
| Return on Total Capital | 214.613 |
| Return on Invested Capital | N/A |
BTCY Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | -664.907 |
| Total Debt to Total Assets | 462.514 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | -345.071 |